Novan Therapeutics

Novan Therapeutics

Novan Therapeutics

Novan is a clinical-stage drug development company developing deliverable nitric oxide.
Founded
2008
Raised
$90.3M
Follow us
Alexa global traffic share
Latest funding Show all
$30,000,000
Angel - 2015
$50,000,000
Venture capital - 2015
Malin
Team Size
50+
Employees
$30,000,000 Angel
Xconomy

Novan Therapeutics Raises $30M Ahead of Acne Drug’s Phase 3 Trial

Health Funding